Common Equity: The sum of all common equity items.
ADC Therapeutics SA (ADCT) had Common Equity of $-185.83M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$23.06M |
|
$-6.41M |
|
$1.70M |
|
$21.36M |
|
$40.98M |
|
$-17.92M |
|
$11.11M |
|
$-6.81M |
|
$-6.81M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-17.92M |
|
$-17.81M |
|
127.07M |
|
127.07M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$306.33M |
|
-- |
|
$16.82M |
|
$323.15M |
|
$70.16M |
|
$112.45M |
|
$438.82M |
|
$508.98M |
|
|
Common Equity |
$-185.83M |
$-185.83M |
|
$-185.83M |
|
125.75M |
|
| Cash Flow Statement Financials | |
$-141.17M |
|
$0.40M |
|
$150.94M |
|
$250.87M |
|
$261.34M |
|
$10.47M |
|
$6.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.37 |
|
-- |
|
-- |
|
-1.53 |
|
-0.62 |
|
92.63% |
|
-77.71% |
|
-77.71% |
|
-- |
|
-29.55% |
|
-27.80% |
|
$-140.78M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.41 |
|
0.79 |
|
113.65 |
|
3.45% |
|
3.45% |
|
-1.98% |
|
8.73% |
|
$-1.48 |
|
$-1.11 |
|
$-1.11 |
|